301 Route 304, Suite 4, Bardonia, NY 10954 | Phone: (845) 507-0555 | Fax: (845) 507-0012 | Mon-Thu 9:00am - 8:00pm | Fri 9:00am - 7:00pm | Sat 10:00am - 4:00pm | Sun 10:00am - 3:00pm
Get Healthy!
- Posted December 16, 2025
Is Tamoxifen Alone a Viable Option for Women with Low-Risk DCIS Breast Cancer?
In a new study, women with very early-stage DCIS breast cancer taking tamoxifen alone had higher recurrence rates than researchers expected. But they say the incidence of invasive breast cancer was still low at 5 years, suggesting tamoxifen alone may be an option in “carefully selected patients.”
